Detection of alterations in membrane metabolism during neoadjuvant chemotherapy in patients with breast cancer using phosphorus magnetic resonance spectroscopy at 7 Tesla
Open Access
- 27 October 2014
- journal article
- research article
- Published by Springer Nature in SpringerPlus
- Vol. 3 (1) , 634
Abstract
Here we investigate the feasibility of tumor metabolism monitoring in T1c to T3 breast cancer during neoadjuvant chemotherapy by means of phosphorus (31P) magnetic resonance spectroscopy at 7 tesla (T). Five breast cancer patients were examined using a 31P MRSI sequence, prior to-, halfway-, and after neoadjuvant chemotherapy. The 31P MRSI data were analyzed on group and individual level and compared to a spectrum of a group of healthy volunteers. Ratios of phosphomonoesters (PME) to phosphodiesters (PDE) and phosphomonoesters to inorganic phosphate (Pi) were determined. Histopathologic assessment showed four partial responders and one complete responder to chemotherapy. The 31P spectrum of the patient group was distinctly different from the 31P spectrum of healthy volunteers and transformed its shape during the course of chemotherapy towards the shape of the spectrum of the healthy volunteers. Prior to chemotherapy the PME to PDE signal ratio and the PME to Pi signal ratio were high, and during the course of the chemotherapy these ratios normalized to the value of the healthy volunteers. Metabolite T2 values in tumor tissue tended to be lower than those for healthy glandular tissue. Assessment of individual patients showed that four out of five had a significant drop of the PME to Pi ratio by a factor of 2 or more. On average, the pH of the tumor, calculated from chemical shift variation of Pi, was 0.19 units lower before chemotherapy. We have demonstrated that the sensitivity of 31P MRSI in breast cancer at 7 T is sufficient to detect alterations in membrane metabolism during neoadjuvant chemotherapy, which may be used for early assessment of treatment efficacy.Keywords
This publication has 24 references indexed in Scilit:
- Adiabatic multi‐echo 31P spectroscopic imaging (AMESING) at 7 T for the measurement of transverse relaxation times and regaining of sensitivity in tissues with short T2* valuesNMR in Biomedicine, 2013
- Feasibility of 7 Tesla Breast Magnetic Resonance Imaging Determination of Intrinsic Sensitivity and High-Resolution Magnetic Resonance Imaging, Diffusion-Weighted Imaging, and 1H-Magnetic Resonance Spectroscopy of Breast Cancer Patients Receiving Neoadjuvant TherapyInvestigative Radiology, 2011
- 31P MRSI and 1H MRS at 7 T: initial results in human breast cancerNMR in Biomedicine, 2011
- Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft modelsBMC Cancer, 2010
- Assessment of 31P relaxation times in the human calf muscle: A comparison between 3 T and 7 T in vivoMagnetic Resonance in Medicine, 2009
- Carr-Purcell-Meiboom-Gill imaging of prostate cancer: quantitative T2 values for cancer discriminationMagnetic Resonance Imaging, 2008
- 31P MRS as an early prognostic indicator of patient response to chemotherapyMagnetic Resonance in Medicine, 1992
- PRETBANSPLANT ASSESSMENT OF RENAL VIABILITY BY PHOSPHORUS-31 MAGNETIC RESONANCE SPECTROSCOPYTransplantation, 1989
- IN-VIVO 31P MAGNETIC RESONANCE SPECTROSCOPY FOR MONITORING TREATMENT RESPONSE IN BREAST CANCERThe Lancet, 1989
- Therapeutic response of breast carcinoma monitored by 31P MRS in situMagnetic Resonance in Medicine, 1989